Shuo Han

Shuo Han

Auto-generated profile, based on publicly available information

Shuo Han

State Key Laboratory of Drug Research, State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Cell Research
Verified
Journal Article
Open access
PDF file
XWXinwei Wang
Xinwei Wang
MWMu Wang
Mu Wang
TXTuo Xu
Tuo Xu
YFYe Feng
Ye Feng
QSQiang Shao
Qiang Shao
BWBeili Wu
Beili Wu
Heterodimerization of the metabotropic glutamate receptors (mGlus) has shown importance in the functional modulation of the receptors and offers potential drug targets for treating central nervous system diseases. However, due to a lack of molecular details of the mGlu heterodimers, understanding of the mechanisms underlying mGlu heterodimerization and activation is limited. Here we report twelve cryo-electron microscopy (cryo-EM) structures of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers in different conformational states, including inactive, intermediate inactive, intermediate active and fully active conformations. These structures provide a full picture of conformational rearrangement of mGlu2–mGlu3 upon activation. The Venus flytrap domains undergo a sequential conformational change, while the transmembrane domains exhibit a substantial rearrangement from an inactive, symmetric dimer with diverse dimerization patterns to an active, asymmetric dimer in a conserved dimerization mode. Combined with functional data, these structures reveal that stability of the inactive conformations of the subunits and the subunit–G protein interaction pattern are determinants of asymmetric signal transduction of the heterodimers. Furthermore, a novel binding site for two mGlu4 positive allosteric modulators was observed in the asymmetric dimer interfaces of the mGlu2–mGlu4 heterodimer and mGlu4 homodimer, and may serve as a drug recognition site. These findings greatly extend our knowledge about signal transduction of the mGlus.

27 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
WZWenli Zhao
Wenli Zhao
WZWenru Zhang
Wenru Zhang
MWMu Wang
Mu Wang
MLMinmin Lu
Minmin Lu
SCShutian Chen
Shutian Chen
QZQiang Zhao
Qiang Zhao
Neuromedin U receptor 2 (NMU2), an emerging attractive target for treating obesity, has shown the capability in reducing food intake and regulating energy metabolism when activated. However, drug development of NMU2 was deferred partially due to the lack of structural information. Here, we present the cryo-electron microscopy (cryo-EM) structure of NMU2 bound to the endogenous agonist NmU-25 and Gi1 at 3.3 Å resolution. Combined with functional and computational data, the structure reveals the key factors that govern the recognition and selectivity of peptide agonist as well as non-peptide antagonist, providing the structural basis for design of novel and highly selective drugs targeting NMU2. In addition, a 25-degree rotation of Gi protein in reference to NMU2 is also observed compared in other structures of class A GPCR—Gi complexes, suggesting heterogeneity in the processes of G protein-coupled receptors (GPCRs) activation and G protein coupling.

30 November 2024 in Cell Reports
Verified
Journal Article
Open access
YKYudun Ke
Yudun Ke
YHYimiao Huang
Yimiao Huang
CYCuiying Yi
Cuiying Yi
LMLimin Ma
Limin Ma
XCXiaojing Chu
Xiaojing Chu
SHShuo Han
Shuo Han
Free fatty acid receptors (FFARs) play critical roles in metabolic regulation and are potential therapeutic targets for metabolic and inflammatory diseases. A comprehensive understanding of the activation mechanisms and endogenous ligand selectivity of FFARs is essential for drug discovery. Here, we report two cryoelectron microscopy structures of the human FFAR1 bound to the endogenous ligand docosahexaenoic acid (DHA) and Gi1 protein as well as FFAR2 in complex with butyrate and Gi1 at 3.2 Å and 3.3 Å resolution, respectively. These structures highlight that distinct locations and sizes of the orthosteric ligand binding pockets are crucial determinants of the endogenous ligand selectivity of this receptor subfamily. Additionally, computational analysis reveals a potential allosteric ligand binding pocket in FFAR2. Furthermore, we observe that the upward movement of helix V upon endogenous ligand binding is responsible for receptor activation. These insights will significantly aid in the development of drugs targeting this receptor family.

5 November 2025 in iScience
Verified
Journal Article
Open access
SCShutian Chen
Shutian Chen
XHXuteng Han
Xuteng Han
YZYuxia Zhang
Yuxia Zhang
LMLimin Ma
Limin Ma
CYCuiying Yi
Cuiying Yi
BWBeili Wu
Beili Wu
In response to the chemokine-like peptide GPR15L, G protein-coupled receptor 15 (GPR15) is crucial for immune cell trafficking and inflammatory diseases. However, understanding of its physiology and pathology is hindered by lack of molecular details of the interaction between GPR15 and the full-length GPR15L. Here, we report the structure of GPR15 bound to the full-length GPR15L and Gi3 protein. Combined with mutagenesis data, this structure reveals key interactions that define ligand recognition and a subpocket that governs GPR15L selectivity and receptor activation. Molecular dynamics simulations suggest that sulfation modifications in the N-terminal region of GPR15 may play a role in stabilizing the binding between GPR15 and the core region of GPR15L. Furthermore, molecular docking of some potential small-molecule antagonists suggests a conserved molecular pattern of these ligands inhibiting receptor activation. These findings provide essential insight into functional modulation of GPR15 and would facilitate development of therapeutic strategies for treatment of inflammation and immune diseases.

20 April 2026 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
QTQiuxiang Tan
Qiuxiang Tan
YYYu Yu
Yu Yu
XHXuteng Han
Xuteng Han
KLKezhen Liu
Kezhen Liu
SHShuo Han
Shuo Han
QZQiang Zhao
Qiang Zhao
Bitter taste receptors (T2Rs) are considered attractive drug targets. However, the ligand recognition and selectivity of these receptors remain elusive, hampering their drug development. Here we present seven structures of human T2R14 and T2R46 in apo or ligand-bound state. Combined with molecular docking and mutagenesis data, the structures reveal an extracellular ligand-binding site in T2R14 for most of its ligands, which is different from the intracellular binding site reported recently. In contrast, T2R46 exhibits a conserved binding pocket that accommodates various ligands with distinct interaction patterns. Furthermore, the second extracellular loop in T2R14 and T2R46 acts as a tethered agonist to potentially facilitate agonist response of these two receptors to the weak tastant agonists. These findings could accelerate drug discovery targeting T2Rs.

11 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SLShuling Lin
Shuling Lin
CZChenhui Zhang
Chenhui Zhang
JWJiaxin Wei
Jiaxin Wei
SLShanshan Li
Shanshan Li
JYJie Yu
Jie Yu
BWBeili Wu
Beili Wu
The arrestin-mediated regulation of signaling through the metabotropic glutamate receptors (mGlus) is fundamental mechanism modulating excitatory transmission and synaptic plasticity. However, molecular details of arrestin engagement are elusive for these dimeric receptors. Here we report the structures of mGlu5 and mGlu7 bound to β-arrestin 1 (βarr1) and their endogenous agonist glutamate. The structures reveal a symmetric interaction pattern of two βarr1 molecules coupling solely to the membrane-proximal C-terminal regions of the active mGlu5, and an asymmetric binding manner with one βarr1 interacting with both transmembrane domains in the inactive mGlu7. Supported by mass spectrometry and functional data, the mGlus adopt multiple subtype-dependent arrestin binding modes that are determined by both the receptor core and C terminus. Furthermore, the activities of arrestin-mediated desensitization and endocytosis of the mGlus are likely associated with the distinct arrestin binding patterns, which may account for the differential signaling profiles of different mGlu subtypes.